Generation Bio (GBIO)
(Delayed Data from NSDQ)
$2.99 USD
-0.27 (-8.28%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $3.00 +0.01 (0.33%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Income Statements
Fiscal Year end for Generation Bio Co falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 6 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 6 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 144 | 141 | 119 | 81 | 62 |
Income After Depreciation & Amortization | -139 | -141 | -119 | -81 | -62 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | -12 | -5 | 0 | -1 | -1 |
Pretax Income | -127 | -137 | -119 | -81 | -61 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -127 | -137 | -119 | -81 | -61 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -127 | -137 | -119 | -81 | -61 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -133 | -136 | -115 | -78 | -60 |
Depreciation & Amortization (Cash Flow) | 5 | 5 | 5 | 3 | 2 |
Income After Depreciation & Amortization | -139 | -141 | -119 | -81 | -62 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 64.48 | 58.12 | 56.30 | 27.26 | NA |
Diluted EPS Before Non-Recurring Items | -1.96 | -2.35 | -2.12 | -2.95 | NA |
Diluted Net EPS (GAAP) | -1.96 | -2.35 | -2.12 | -2.95 | NA |
Fiscal Year end for Generation Bio Co falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 2.88 | 2.15 | 0.88 | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 2.88 | 2.15 | 0.88 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 41.30 | 33.50 | 34.80 | 34.87 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -38.42 | -31.35 | -33.92 | -34.87 |
Non-Operating Income | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | NA | -3.24 | -3.09 | -2.85 | -2.77 |
Pretax Income | NA | -35.19 | -28.27 | -31.07 | -32.09 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -35.19 | -28.27 | -31.07 | -32.09 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -35.19 | -28.27 | -31.07 | -32.09 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 66.06 | 65.91 | 65.66 | 60.23 |
Diluted EPS Before Non-Recurring Items | NA | -0.53 | -0.43 | -0.47 | -0.53 |
Diluted Net EPS (GAAP) | NA | -0.53 | -0.43 | -0.47 | -0.53 |